Nutex Health (NASDAQ:NUTX) Trading Down 5% - Here's Why

Nutex Health Inc. (NASDAQ:NUTX - Get Free Report) dropped 5% on Tuesday . The stock traded as low as $125.49 and last traded at $127.05. Approximately 41,320 shares traded hands during mid-day trading, a decline of 46% from the average daily volume of 76,534 shares. The stock had previously closed at $133.77.

Analysts Set New Price Targets

A number of analysts have weighed in on the company. Maxim Group upped their price target on Nutex Health from $100.00 to $225.00 and gave the company a "buy" rating in a research report on Tuesday, May 20th. Wall Street Zen lowered shares of Nutex Health from a "strong-buy" rating to a "buy" rating in a report on Thursday, May 22nd. Finally, Benchmark upped their price objective on Nutex Health from $150.00 to $300.00 and gave the stock a "buy" rating in a research report on Thursday, May 15th.

Nutex Health Stock Down 9.8%

The firm has a market cap of $670.60 million, a price-to-earnings ratio of -12.92 and a beta of 0.04. The firm has a 50 day moving average of $138.10 and a 200 day moving average of $78.86. The company has a quick ratio of 1.74, a current ratio of 1.77 and a debt-to-equity ratio of 3.36.

Nutex Health (NASDAQ:NUTX - Get Free Report) last released its quarterly earnings data on Tuesday, May 13th. The company reported $2.56 earnings per share for the quarter, beating analysts' consensus estimates of ($0.15) by $2.71. Nutex Health had a negative net margin of 14.09% and a negative return on equity of 51.27%. The firm had revenue of $211.79 million for the quarter, compared to analyst estimates of $81.09 million.

Insider Transactions at Nutex Health

In related news, CFO Jon Christian Bates bought 1,000 shares of the business's stock in a transaction that occurred on Tuesday, April 8th. The stock was bought at an average cost of $81.81 per share, for a total transaction of $81,810.00. Following the completion of the transaction, the chief financial officer now owns 4,888 shares of the company's stock, valued at approximately $399,887.28. The trade was a 25.72% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 36.92% of the company's stock.

Institutional Investors Weigh In On Nutex Health

Several institutional investors and hedge funds have recently modified their holdings of NUTX. Topline Capital Management LLC bought a new position in shares of Nutex Health in the fourth quarter worth approximately $5,690,000. American Century Companies Inc. bought a new position in shares of Nutex Health during the 4th quarter valued at $1,362,000. Ancora Advisors LLC bought a new stake in shares of Nutex Health in the fourth quarter worth $1,334,000. Essex Investment Management Co. LLC boosted its position in Nutex Health by 45.4% in the fourth quarter. Essex Investment Management Co. LLC now owns 105,809 shares of the company's stock worth $3,353,000 after purchasing an additional 33,024 shares during the last quarter. Finally, Russell Investments Group Ltd. purchased a new position in shares of Nutex Health in the fourth quarter worth approximately $672,000. 5.32% of the stock is owned by hedge funds and other institutional investors.

About Nutex Health

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.